Comparative Safety Surveillance of Triple (IDA) Versus Dual Therapy (DA) in Mass Drug Administration for Elimination of Lymphatic Filariasis in Kenya: A Cohort Event Monitoring Study

INTRODUCTION: Dual diethylcarbamazine and albendazole (DA) therapy is the standard mass drug administration (MDA) regimen for lymphatic filariasis in Kenya. Following the recent World Health Organization recommendation, Kenya piloted triple therapy with ivermectin, diethylcarbamazine, and albendazol...

Descripción completa

Detalles Bibliográficos
Autores principales: Khaemba, Christabel, Barry, Abbie, Omondi, Wyckliff P., Kirui, Elvis, Oluka, Margaret, Parthasarathi, Gurumurthy, Njenga, Sammy M., Guantai, Anastacia, Aklillu, Eleni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584738/
https://www.ncbi.nlm.nih.gov/pubmed/37552438
http://dx.doi.org/10.1007/s40264-023-01338-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584738/
https://www.ncbi.nlm.nih.gov/pubmed/37552438
http://dx.doi.org/10.1007/s40264-023-01338-9

Ejemplares similares